Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA)

NCT01012063 ↗

Completed 54 enrolled Seoul National University Bundang Hospital

RandomizedParallel-groupOpen-labelPrevention

Summary

The object of this study is to evaluate whether low dose intravenous iron and erythropoietin (Epo) can decrease transfusion requirement after the bilateral TKRA.

Timeline

Start: 2008-08
Primary completion: 2009-10
Completion: 2009-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Iron sucrose	Unknown	200 mg	Intravenous
Subject	erythropoietin-β	Unknown	3000 iu	Subcutaneous

Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA)

Summary

Timeline

Drugs

Indications